Thinking from event of Kangtai hepatitis B vaccination

Science China Life Sciences

Volumn 57, Issue 5, 2014, Pages 555-556

  Ruan, Li ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ADVERSE EFFECTS; CHILD DEATH; CHINA; DRUG DATABASE; DRUG INDUSTRY; DRUG SURVEILLANCE PROGRAM; ETIOLOGY; HEPATITIS B; HUMAN; INFANT; MASS IMMUNIZATION; PUBLIC HEALTH;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CHINA; DATABASES, PHARMACEUTICAL; DRUG INDUSTRY; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT DEATH; MASS VACCINATION; NATIONAL HEALTH PROGRAMS; VACCINES, SYNTHETIC;

EID: 84900845591     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-014-4624-3     Document Type: Article

References (4)

1. Liu CB. Epidemiology of viral hepatitis B. In: Liu XG, Qi ZB, Xiong SS, eds. The Laboratory Diagnosis of Viral Hepatitis. 2nd ed. Beijing: People Health Publication, 1999. 107-110.
2. Bureau of Disease Control and Prevention of Ministry of Health of China and Chinese Center for Disease Control and Prevention. Report of Seroepidemiology Survey of Viral Hepatitis B in China. Beijing: People Health Publication, 2011.
3. Ruan L. Genetic engineering subunit vaccine. In: Zhao K, ed. Vaccine. Beijing: People Health Publication, 2013. 396-400.
4. China Food and Drug Administration and National Health and Family Planning Commission of the People's Republic of China. Media Briefing on the Event of Hepatitis B Vaccination. http://www. sfda. gov. cn/WS01/CL0051/95394. html, 24 Dec 2013.